Gene therapy of malignant solid tumors by targeting erbB2 receptors and by activating T cells.
about
Efficient production of CYTL1 protein using mouse IgGκ signal peptide in the CHO cell expression systemChimaeric antigen receptor T-cell therapy for tumour immunotherapy.Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells.
P2860
Gene therapy of malignant solid tumors by targeting erbB2 receptors and by activating T cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Gene therapy of malignant soli ...... ors and by activating T cells.
@en
Gene therapy of malignant soli ...... ors and by activating T cells.
@nl
type
label
Gene therapy of malignant soli ...... ors and by activating T cells.
@en
Gene therapy of malignant soli ...... ors and by activating T cells.
@nl
prefLabel
Gene therapy of malignant soli ...... ors and by activating T cells.
@en
Gene therapy of malignant soli ...... ors and by activating T cells.
@nl
P2093
P2860
P356
P1476
Gene therapy of malignant soli ...... ors and by activating T cells.
@en
P2093
Chao-Yan Wang
Da-Ming Shan
He-Ping Chen
Hong-Zhi Li
Lu-Xi Shen
Shi-Zhen Su
Wang-Xiong Hu
Wen-Jun Sui
P2860
P304
P356
10.1089/CBR.2012.1246
P577
2012-09-18T00:00:00Z